Major Ingredients Water, Butylene Glycol, 1,2-Hexanediol, Glycerin, Niacinamide, Hydrogenated Coconut Oil, Hydrolyzed Sodium Hyaluronate(9,749 ppm), Cetearyl Alcohol, Glutathione(6,000 ppm), Glyceryl Stearates, Hydrogenated Lecithin, C14-22 Alcohols, Polyglyceryl-10 Stearate, Cetearyl Olivate, Methyl Glucose Sesquistearate, Isoamyl Laurate, Carbomer, Sorbitan Olivate, Polyglyceryl-4 Caprate, Tromethamine, Sodium Hyaluronate(1,000 ppm), Thujopsis Dolabrata Branch Extract, Betaine, Abies Sibirica Oil, Cryptomeria Japonica Leaf Extract, Citrus Junos Peel Oil, Phyllostachys Pubescens Shoot Bark Extract, Chamaecyparis Obtusa Leaf Extract, C12-20 Alkyl Glucoside, Hydrolyzed Hyaluronic Acid(700 ppm), Hyaluronic Acid(700 ppm), Xanthan Gum, Pentylene Glycol, Adenosine, Disodium EDTA, Maltodextrin, Hydrolyzed Gardenia Florida Extract, Glyceryl Glucoside, Ethylhexylglycerin, Glucose, Silybum Marianum Extract, Polyglyceryl-10 Laurate, Dimethylsilanol Hyaluronate(300 ppb), Copper Tripeptide-1, Acetyl Hexapeptide-8, Cyanocobalamin, Palmitoyl Tetrapeptide-7, Palmitoyl Tripeptide-1, Palmitoyl Pentapeptide-4, Pyridoxine HCl, Hydroxypropyltrimonium Hyaluronate(50 ppb), Potassium Hyaluronate(35 ppb), Sodium Acetylated Hyaluronate(15 ppb), Riboflavin, Fragrance, Citronellol, Geraniol, Hexyl Cinnamal, Hydroxycitronellal, Limonene, Linalool Ingredients subject to change at manufacturer's discretion
![semaglutide ms Product ion spectra of protonated A liraglutide ([M + 4H] 4+ , m/z = optimize results LCMS analysis comparing the DS](https://www.researchgate.net/publication/384736155/figure/fig2/AS:11431281288142806@1730516151964/LC-MS-analysis-comparing-the-DS-of-originator-semaglutide-with-a-synthetically-produced_Q320.jpg)
BPC-157 10 mg Research peptide targeting repair, regeneration & tissue support BPC-157, also known as Body Protection Compound 157 , is a synthetic peptide derived from a naturally occurring protein fragment in the gastric juice
In clinical trials, individuals using semaglutide reported an average weight loss of around 15% of their body weight over 68 weeks, while tirzepatide users experienced reductions as high as 20% in some studies
Reusing injection supplies increases infection risk, causes needle dulling that makes injections more painful, and can introduce contaminants into the vial
Its intellectual property, particularly around semaglutide, ensures legal monopolies through much of this decade